The ASH Meeting on Hematologic Malignancies has transitioned to a virtual setting in their efforts to keep attendees, presenters, and ASH staff safe in the midst of the coronavirus pandemic.

They are committed to continuing our work with you, our global network of researchers and clinicians, to better understand, prevent, and treat blood disorders, and we are excited to share this new and unique virtual experience with you later this summer.